George K Ng insider trades

Open-market stock purchases and sales by George K Ng, Chief Executive Officer at Processa Pharmaceuticals, Inc, from SEC Form 4 filings since Aug 3, 2015.

Track record: 8% of 12 scored buys are up 5% or more since purchase, averaging -19%.

Recent trades

DateStockTradeValue
Aug 8, 2026PCSA Processa Pharmaceuticals, IncBought (not open market)—
Aug 8, 2026PCSA Processa Pharmaceuticals, IncBought (not open market)—
Jul 26, 2026PCSA Processa Pharmaceuticals, IncBought (not open market)—
Jul 1, 2026PCSA Processa Pharmaceuticals, IncBought$5.9K
Jun 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
May 29, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
May 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
Apr 30, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
Apr 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
Apr 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
Apr 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
Mar 31, 2026PCSA Processa Pharmaceuticals, IncBought$5.4K
Mar 31, 2026PCSA Processa Pharmaceuticals, IncBought$5.4K
Feb 12, 2026HURA TuHURA Biosciences, Inc./NVBought (not open market)—

Companies traded

  • PCSA Processa Pharmaceuticals, Inc: 12 buys, last Aug 8, 2026
  • HURA TuHURA Biosciences, Inc./NV: other filings, last Feb 12, 2026
  • KTRA Kintara Therapeutics, Inc: other filings, last Oct 18, 2024
  • SRNE Sorrento Therapeutics, Inc: 5 buys, 1 sale, last Feb 28, 2018

Get free alerts when George K Ng files a new trade →